Nemaura Medical Valuation
| NMRDDelisted Stock | USD 0.93 0.01 1.06% |
Today, the firm appears to be overvalued. Nemaura Medical secures a last-minute Real Value of $0.74 per share. The latest price of the firm is $0.93. Our model forecasts the value of Nemaura Medical from analyzing the firm fundamentals such as Shares Owned By Insiders of 48.30 %, current valuation of 22.58 M, and Return On Equity of -7.24 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Nemaura Medical's price fluctuation is very steady at this time. Calculation of the real value of Nemaura Medical is based on 3 months time horizon. Increasing Nemaura Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Nemaura pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Nemaura Medical. Since Nemaura Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Nemaura Pink Sheet. However, Nemaura Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.93 | Real 0.74 | Hype 0.93 | Naive 0.84 |
The real value of Nemaura Pink Sheet, also known as its intrinsic value, is the underlying worth of Nemaura Medical Company, which is reflected in its stock price. It is based on Nemaura Medical's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Nemaura Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Nemaura Medical helps investors to forecast how Nemaura pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Nemaura Medical more accurately as focusing exclusively on Nemaura Medical's fundamentals will not take into account other important factors: Nemaura Medical Total Value Analysis
Nemaura Medical is now projected to have valuation of 22.58 M with market capitalization of 2.43 M, debt of 20.03 M, and cash on hands of 14.75 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Nemaura Medical fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
22.58 M | 2.43 M | 20.03 M | 14.75 M |
Nemaura Medical Investor Information
About 48.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.39. Nemaura Medical last dividend was issued on the 5th of December 2019. The entity had 1:10 split on the 5th of December 2019. Based on the analysis of Nemaura Medical's profitability, liquidity, and operating efficiency, Nemaura Medical is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.Nemaura Medical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Nemaura Medical has an asset utilization ratio of 0.53 percent. This indicates that the Company is making $0.00529 for each dollar of assets. An increasing asset utilization means that Nemaura Medical is more efficient with each dollar of assets it utilizes for everyday operations.Nemaura Medical Ownership Allocation
Nemaura Medical holds a total of 28.9 Million outstanding shares. Nemaura Medical holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.Nemaura Medical Profitability Analysis
The company reported the previous year's revenue of 77.04 K. Net Loss for the year was (14.14 M) with loss before overhead, payroll, taxes, and interest of (1.48 M).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Nemaura Medical's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Nemaura Medical and how it compares across the competition.
About Nemaura Medical Valuation
The pink sheet valuation mechanism determines Nemaura Medical's current worth on a weekly basis. Our valuation model uses a comparative analysis of Nemaura Medical. We calculate exposure to Nemaura Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Nemaura Medical's related companies.Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York. Nemaura Med operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 32 people.
8 Steps to conduct Nemaura Medical's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Nemaura Medical's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Nemaura Medical's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Nemaura Medical's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Nemaura Medical's revenue streams: Identify Nemaura Medical's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Nemaura Medical's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Nemaura Medical's growth potential: Evaluate Nemaura Medical's management, business model, and growth potential.
- Determine Nemaura Medical's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Nemaura Medical's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Nemaura Medical Growth Indicators
Investing in growth stocks can be very risky. If the company such as Nemaura Medical does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 24.9 M |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Consideration for investing in Nemaura Pink Sheet
If you are still planning to invest in Nemaura Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Nemaura Medical's history and understand the potential risks before investing.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Stocks Directory Find actively traded stocks across global markets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |